Results 171 to 180 of about 76,642 (241)

Improving Maximum Tolerated Dose Selection in Model-Assisted Designs for Phase I Trials Through Bayesian Dose-Response Model. [PDF]

Pharm Stat
Wakayama R, Momozaki T, Ando S.
europepmc   +1 more source

Behavioral and demographic factors associated with glycemic control in adults with type 2 diabetes mellitus: a cross-sectional study. [PDF]

BMC Health Serv Res
Innab A, Kerari A.
europepmc   +1 more source

Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Combination with Chemotherapy in Children with Advanced Malignancies: Arm K of the AcSé-ESMART Trial. [PDF]

Target Oncol
Rubio-San-Simón A, Marshall LV, Karamouza E, André N, Abbou S, Rubino J, Nebchi S, Aerts I, Thebaud E, Brisset C, Ducassou S, Le Teuff G, Geoerger B.   +12 more
europepmc   +1 more source

A Decade of Oncolytic Virotherapy in Pediatric Cancers: A Systematic Review of Safety, Immune Awakening, and Emerging Efficacy. [PDF]

Cureus
BinSharhan AS, AlAbdullah AM, Alabdullatif SF, Aboushark YY, Alateeq NM, Alhajjaj WA, Alrabea HO, Saeedi F.   +7 more
europepmc   +1 more source

Body Mass Index Subclassification and Future Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver-Related Events. [PDF]

J Nutr
Zhang S, Coral DE, Huo Z, Borné Y, Zheng MH, Huang T, Qi L.   +6 more
europepmc   +1 more source

A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol. [PDF]

PLoS One
Kurokawa T, Iinuma T, Ebisu H, Yanagidaira T, Inaba Y, Fujiwara T, Hattori Y, Fukazawa T, Aoki T, Koseki H, Hanaoka H, Hanazawa T, Motohashi S.   +12 more
europepmc   +1 more source

Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights. [PDF]

Clin Cancer Res
Brodsky AL, Asare A, Fellman B, Anderson K, Yao J, Lee S, Tran H, Xu X, Liu J, Celestino J, Hajek RA, Morgan MB, Mohammad M, Soliman P, Shafer A, Sood AK, Bodurka D, Fleming ND, Onstad Grinsfelder M, Milojevic L, Jazaeri AA, Mills GB, Coleman RL, Westin SN.   +23 more
europepmc   +1 more source

Resilient security architecture for smart buildings using DLT powered encryption. [PDF]

Sci Rep
Priyadarshini I, Puri V, Kataria A, Solanki VK, Seo JT, Min H.   +5 more
europepmc   +1 more source

Impact of double lumen tube length variations on lung isolation: A clinical observation. [PDF]

J Anaesthesiol Clin Pharmacol
Gautam S, Kumar S, Bagga A, Mishra NK.
europepmc   +1 more source

Expanding donor liver utilization: triple recipient strategy using split, domino, and auxiliary techniques. [PDF]

Hepatobiliary Surg Nutr
Sun Q, Ding H, Zhang Y, Zhou X, Sun Z, Han X, Fang F, Yang L, Yan S, Ding Y, Wang W.   +10 more
europepmc   +1 more source